Assembly Biosciences IncQ) expected to post a loss of $1.36 a share - Earnings Preview
Assembly Biosciences IncQ) is projected to report a loss of $1.36 per share and a 26.6% decline in quarterly revenue to $6.262 million for the period ending June 30, 2025. The average analyst rating remains "buy" with a median 12-month price target of $31.00, reflecting a potential upside of 40.6% from the last closing price of $18.40. Previous earnings estimates show a mix of beats and misses in recent quarters.
- Assembly Biosciences Inc (ASMB.OQ) (ASMB.O) is expected to
show a fall in quarterly revenue when it reports results on August 6 (estimated) for the period ending June 30 2025
- The South San Francisco California-based company is expected to report a 26.6% decrease in revenue to $6.262 million from $8.53 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.
- LSEG’s mean analyst estimate for Assembly Biosciences Inc is for a loss of $1.36 per share.
- The current average analyst rating on the shares is “buy” and the breakdown of recommendations is 2 “strong buy” or “buy,” 1 “hold” and no “sell” or “strong sell.”
- The mean earnings estimate of analysts was unchanged in the last three months.
- Wall Street’s median 12-month price target for Assembly Biosciences Inc is $31.00, about 40.6% above its last closing price of $18.40 Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Mar. 31 2025 -1.60 -1.60 -1.17 Beat 26.9
Dec. 31 2025 -2.04 -1.57 Beat 23
Sep. 30 2024 -2.02 -2.02 -1.51 Beat 25.2
Jun. 30 2024 -2.23 -2.23 -1.98 Beat 11.2
Mar. -3.23 -3.23 -1.66 Beat 48.6
31 2024
Dec. 31 2023 -2.88 -2.15 Beat 25.3
Sep. 30 2023 -2.76 -3.24 Missed -17.4
Jun. 30 2023 -3.46 -3.48 -3.84 Missed -10.3
This summary was machine generated August 4 at 22:00 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
